Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06593405

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age-Related Macular Degeneration Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Age range

50 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

MCPHS 10 Lincoln Square

Worcester, Massachusetts, 01608, United States

Location status: Recruiting

Location contact

Michelle Dowling, Clinical Doctorate

PRINCIPAL_INVESTIGATOR

Michelle Dowling, Clinical Doctorate (OTD)

CONTACT

[email protected]

508-373-5851

About this study

Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clients with AMD, DR or Glaucoma
  • Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Exclusion criteria

  • Clients with other age related eye diseases other than AMD, DR or Glaucoma.
  • Clients who do not wish to participate in this study.

Treatment and study plan

occupational therapy interventions for low vision care

Combination Product

Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Primary outcomes

  1. Revised Self Report Assessment of Functional Visual

    Time frame: Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later

    A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.

  2. MediCog Screening Tool

    Time frame: Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later

    The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.

Study contacts

Contact information is provided by the study sponsor or research team.

Michelle Dowling, OTD

CONTACT

[email protected]

508-373-5851

Sponsors and collaborators

Lead sponsor

MCPHS University

Other

Registry information

Official study title

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 19, 2024
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.